Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Clinics in Arkansas

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

What Arkansas law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and listings with their verification status.

Arkansas at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async not allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Clinics serving Arkansas

No verified clinics serving Arkansas are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Arkansas

Yes, with a stricter first-visit rule than most states. An Arkansas resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription from an Arkansas-licensed provider, including by telemedicine under the Arkansas Telemedicine Act (Ark. Code 17-80-401 through 17-80-407), but a new telemedicine patient relationship cannot rest on an internet questionnaire, email, patient-generated medical history, text message, or fax, alone or in any combination; it needs an in-person exam, an existing relationship, referral, or coverage arrangement, or an evaluation by an Arkansas-licensed provider who has access to a personal health record maintained by a healthcare professional and uses appropriate technology, which for non-controlled drugs can include the telephone. Compounded peptides are available only when eligible under federal 503A rules and dispensed by an Arkansas-licensed pharmacy; an out-of-state pharmacy shipping into Arkansas must hold an Arkansas pharmacy license and keep an Arkansas-licensed pharmacist on staff as pharmacist in charge. [1] [2] [3] [5] [6] [7] [8] [9] [12]

Compounded GLP-1 access in Arkansas

Compounded semaglutide and tirzepatide are limited to documented patient-specific needs after the FDA shortage allowances ended in 2025, and Arkansas's own compounding regulation separately bars routine copies of commercially available drugs. Because Arkansas law does not let an online questionnaire alone establish the patient relationship, Arkansas patients should expect an in-person exam, a referral or existing relationship, or an evaluation by an Arkansas-licensed provider who has access to a personal health record maintained by a healthcare professional (by telephone, video, or other appropriate technology) before a first GLP-1 prescription, and should confirm the dispensing pharmacy holds an Arkansas license with an Arkansas-licensed pharmacist in charge. [2] [3] [5] [7] [13]

Research use only sellers in Arkansas

Only Arkansas-licensed pharmacies may dispense prescription drugs to Arkansas patients, including out-of-state pharmacies licensed under Ark. Code 17-92-401. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling, are not dispensed by a pharmacist, and carry no Arkansas licensing protections. The Arkansas Food, Drug, and Cosmetic Act (Ark. Code 20-56-201 and following) has no separate new-drug approval section, so the unapproved-drug prohibition comes from federal law; the state act does prohibit selling a misbranded drug (Ark. Code 20-56-215) and treats a drug as misbranded unless its labeling bears adequate directions for use and adequate warnings (Ark. Code 20-56-211). [5] [10] [11] [14]

Arkansas notes on specific peptides

  • Semaglutide: Available branded by prescription. A first prescription by telemedicine requires a professional relationship under Ark. Code 17-80-402 and 17-80-403, such as an in-person exam, an existing relationship or referral, or an evaluation by an Arkansas-licensed provider with access to a personal health record maintained by a healthcare professional (telephone allowed for non-controlled drugs). A questionnaire, email, text, fax, or patient-written history, alone or combined, does not qualify. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [2] [3] [13]
  • Tirzepatide: Available branded by prescription. Compounded tirzepatide is limited to documented patient-specific needs since the 503A grace period ended February 18, 2025, and an out-of-state pharmacy shipping it to Arkansas must hold an Arkansas license with an Arkansas-licensed pharmacist in charge. [5] [13]

How to check a clinic in Arkansas

  1. Confirm the prescribing clinician's license with the Arkansas medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Arkansas State Board of Pharmacy license lookup. [1] [5] [6] [7] [12]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Arkansas. [5] [10] [11] [14]

Common questions in Arkansas

Can I get a GLP-1 prescription in Arkansas from an online questionnaire alone?

No. The Arkansas Telemedicine Act requires a professional relationship before telemedicine care and says a relationship established only by an internet questionnaire, email, patient-generated medical history, text message, or fax, or any combination of them, does not count. For a new patient the relationship can come from an in-person exam, a referral from a professional who knows you, or an evaluation by an Arkansas-licensed provider who has access to your personal health record maintained by a healthcare professional and uses appropriate technology, which for non-controlled drugs such as GLP-1s can include a telephone call. [2] [3] [8] [9]

Does a telehealth prescriber need an Arkansas license?

Yes. Ark. Code 17-80-404 and the Arkansas State Medical Board's telemedicine rule (17 CAR 140-3201) require a professional treating a patient located in Arkansas through telemedicine to be licensed in Arkansas. Check the prescriber on the Arkansas State Medical Board license lookup before paying. [4] [9]

All peptide legal questions for Arkansas

Sources

  1. [1]Arkansas State Board of Pharmacy
  2. [2]Arkansas Code 17-80-402, Telemedicine Act definitions (professional relationship, store-and-forward)
  3. [3]Arkansas Code 17-80-403, Establishment of professional relationship
  4. [4]Arkansas Code 17-80-404, Appropriate use of telemedicine
  5. [5]Arkansas Code 17-92-401, Applicability to out-of-state operations (pharmacies)
  6. [6]Code of Arkansas Rules 17 CAR 160-1401, Out-of-state pharmacy regulation
  7. [7]Code of Arkansas Rules 17 CAR 160-2201, Standards for compounding and dispensing compounded products (Ark. R. 2026-88, effective June 29, 2026), accessed 2026-09-22
  8. [8]Code of Arkansas Rules 17 CAR 140-202, Arkansas State Medical Board: minimum standards for establishing patient/provider relationships (paragraph (b)(8)), accessed 2026-09-22
  9. [9]Code of Arkansas Rules 17 CAR 140-3201, Arkansas State Medical Board: requirements for services provided using telemedicine, accessed 2026-09-22
  10. [10]Arkansas Code 20-56-211, Misbranded drug or device (Food, Drug, and Cosmetic Act), accessed 2026-09-22